WO2004081024A3 - Peptide antimicrobien appelé halocyntin, gene codant ledit peptide, vecteur, organisme transforme et composition le contenant - Google Patents

Peptide antimicrobien appelé halocyntin, gene codant ledit peptide, vecteur, organisme transforme et composition le contenant Download PDF

Info

Publication number
WO2004081024A3
WO2004081024A3 PCT/FR2004/000536 FR2004000536W WO2004081024A3 WO 2004081024 A3 WO2004081024 A3 WO 2004081024A3 FR 2004000536 W FR2004000536 W FR 2004000536W WO 2004081024 A3 WO2004081024 A3 WO 2004081024A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptide
halocyntin
composition containing
vector
gene coding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2004/000536
Other languages
English (en)
Other versions
WO2004081024A2 (fr
Inventor
Guillaume Mitta
Richard Galinier
Bernard Banaigs
Eric Lasserre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Université Perpignan Via Domitia
Original Assignee
Centre National de la Recherche Scientifique
Université Perpignan Via Domitia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique, Université Perpignan Via Domitia filed Critical Centre National de la Recherche Scientifique
Priority to DK04717665T priority Critical patent/DK1601768T3/da
Priority to SI200430388T priority patent/SI1601768T1/sl
Priority to US10/547,563 priority patent/US7439418B2/en
Priority to EP04717665A priority patent/EP1601768B1/fr
Priority to PL04717665T priority patent/PL1601768T3/pl
Priority to DE602004006389T priority patent/DE602004006389T2/de
Publication of WO2004081024A2 publication Critical patent/WO2004081024A2/fr
Publication of WO2004081024A3 publication Critical patent/WO2004081024A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/03—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Agronomy & Crop Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Environmental Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne un peptide antibactérien, ci-après appelé halocyntin, isolé à partir d'un extrait d'un invertébré marin, dont la séquence en acides aminés est la suivante: FWGHIWNAVKRVGANALHGAVTGALS, ses dérivés, ses fragments et un polypeptide le comprenant. La présente invention concerne également des organismes hôtes transformés et capables de produire le peptide de l'invention tels que des microorganismes, des cellules animales, des cellules végétales et des plantes. La présente invention se rapporte enfin à une composition antimicrobienne contenant le peptide de l'invention.
PCT/FR2004/000536 2003-03-05 2004-03-05 Peptide antimicrobien appelé halocyntin, gene codant ledit peptide, vecteur, organisme transforme et composition le contenant Ceased WO2004081024A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DK04717665T DK1601768T3 (da) 2003-03-05 2004-03-05 Antimikrobielt peptid betegnet halocyntin, gen, der koder for peptidet, vektor, transformeret organisme og præparat indeholdende det
SI200430388T SI1601768T1 (sl) 2003-03-05 2004-03-05 Antimikroben peptid imenovan halocintin, gen, ki kodira navedeni peptid, vektor, transformiran organizem in sestavek, ki ga vsebuje
US10/547,563 US7439418B2 (en) 2003-03-05 2004-03-05 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide
EP04717665A EP1601768B1 (fr) 2003-03-05 2004-03-05 Peptide antimicrobien appele halocyntin, gene codant ledit peptide, vecteur, organisme transforme et composition le contenant.
PL04717665T PL1601768T3 (pl) 2003-03-05 2004-03-05 Peptyd przeciw mikroorganizmom znany jako halocyntyna, gen kodujący ten peptyd, wektor, transformowany organizm i kompozycja zawierająca ten peptyd
DE602004006389T DE602004006389T2 (de) 2003-03-05 2004-03-05 Antimikrobielles peptid, genannt halocytin; dafür kodierendes gen, vektor, transformierter organismus und zusammensetzung die es enthalten

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0302715A FR2852014B1 (fr) 2003-03-05 2003-03-05 Peptide antimicrobien, gene codant ledit peptide, vecteur, organisme transforme et composition le contenant
FR03/02715 2003-03-05

Publications (2)

Publication Number Publication Date
WO2004081024A2 WO2004081024A2 (fr) 2004-09-23
WO2004081024A3 true WO2004081024A3 (fr) 2004-10-21

Family

ID=32865264

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/000536 Ceased WO2004081024A2 (fr) 2003-03-05 2004-03-05 Peptide antimicrobien appelé halocyntin, gene codant ledit peptide, vecteur, organisme transforme et composition le contenant

Country Status (10)

Country Link
US (1) US7439418B2 (fr)
EP (1) EP1601768B1 (fr)
AT (1) ATE361978T1 (fr)
DE (1) DE602004006389T2 (fr)
DK (1) DK1601768T3 (fr)
ES (1) ES2286617T3 (fr)
FR (1) FR2852014B1 (fr)
PL (1) PL1601768T3 (fr)
PT (1) PT1601768E (fr)
WO (1) WO2004081024A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9677635B2 (en) 2013-07-29 2017-06-13 Borgwarner Inc. Friction material
WO2018093353A1 (fr) 2016-11-15 2018-05-24 Borgwarner Inc. Matériau de friction
CN114984185A (zh) * 2021-04-27 2022-09-02 青岛市中医医院(青岛市海慈医院、青岛市康复医学研究所) 一种多肽在促进皮肤再生中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020028A2 (fr) * 1996-11-06 1998-05-14 The Regents Of The University Of California Clavanines
WO1998038309A1 (fr) * 1997-02-28 1998-09-03 The Regents Of The University Of California Clavaspirines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020028A2 (fr) * 1996-11-06 1998-05-14 The Regents Of The University Of California Clavanines
WO1998038309A1 (fr) * 1997-02-28 1998-09-03 The Regents Of The University Of California Clavaspirines

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JANG W S ET AL: "Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 521, no. 1-3, 19 June 2002 (2002-06-19), pages 81 - 86, XP004362143, ISSN: 0014-5793 *
LEE I H ET AL: "Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium", BBA - GENERAL SUBJECTS, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 1527, no. 3, 15 August 2001 (2001-08-15), pages 141 - 148, XP004296801, ISSN: 0304-4165 *
TOSSI A ET AL: "Molecular diversity in gene-encoded, cationic antimicrobial polypeptides.", CURRENT PHARMACEUTICAL DESIGN. NETHERLANDS 2002, vol. 8, no. 9, 2002, pages 743 - 761, XP008024137, ISSN: 1381-6128 *

Also Published As

Publication number Publication date
PL1601768T3 (pl) 2007-11-30
ATE361978T1 (de) 2007-06-15
DE602004006389T2 (de) 2008-01-10
WO2004081024A2 (fr) 2004-09-23
US20060218665A1 (en) 2006-09-28
DK1601768T3 (da) 2007-09-17
PT1601768E (pt) 2007-08-16
US7439418B2 (en) 2008-10-21
ES2286617T3 (es) 2007-12-01
FR2852014A1 (fr) 2004-09-10
EP1601768B1 (fr) 2007-05-09
EP1601768A2 (fr) 2005-12-07
DE602004006389D1 (de) 2007-06-21
FR2852014B1 (fr) 2008-07-11

Similar Documents

Publication Publication Date Title
WO2007076162A3 (fr) Peptides antimicrobiens de cathelicidine
PL1778720T3 (pl) Antybakteryjne peptydy zawierające wzór zawierający argininę i/lub lizynę
Hong et al. Purification of granulin-like polypeptide from the blood-sucking leech, Hirudo nipponia
WO2007056362A3 (fr) Analogues de glucagon a solubilite et a stabilite physiologiques ameliorees
WO2005009379A3 (fr) Polypeptides pour l'induction d'une reponse immunitaire de protection contre le staphylococcus aureus
WO2009004315A8 (fr) Peptides isolés et leurs utilisations
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
IL188907A (en) Dna fragment encoding a protein extracted from plants of the genus lupinus or produced in recombinant form and use of the protein in preparing plant growth and anti fungal compositions
WO2007051866A3 (fr) Vegetaux presentant des caracteristiques de croissance ameliorees, procede de production de ces dernieres
WO2008113536A8 (fr) Peptides neurotrophiques
WO2003040370A1 (fr) Proteines du metabolisme permettant de lutter contre les mauvaises herbes, leurs genes et leur utilisation
EP2392655A3 (fr) Polypeptides de facteur VII à coagulation
Kim et al. Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii
WO2005024006A3 (fr) Polypeptides du facteur vii de coagulation
PT1151103E (pt) Nac1 - um gene de plantas codificador de um factor de transcricao envolvido no desenvolvimento de cotiledones e raizes laterais
WO2006078680A3 (fr) Polypeptides pour induire une reponse immune protectrice contre staphylococcus aureus
WO2005079523A3 (fr) Nouveaux polypeptides antimicrobiens derives de teleosteens
WO2004009822A3 (fr) Utilisation de genes specifiques myb pour la production de plantes transgeniques tolerantes aux agressions biotique et abiotique
WO2003064614A3 (fr) Peptides de transport et leurs utilisations
WO2007029262A3 (fr) Compositions et methodes d'utilisation de ces dernieres en vue de detecter des virus
WO2006103101A3 (fr) Moyens pour l'inhibition d'anticorps anti-recepteurs $g(b)1 adrenergiques
Utkina et al. Heterologous expression of a synthetic gene encoding a novel hevein-type antimicrobial peptide of Leymus arenarius in Escherichia coli cells
WO2003025153A3 (fr) Proteines ameliorees et methodes liees a leur utilisation
WO2002014345A3 (fr) Peptides antimicrobiens isoles a partir de mastocytes
WO2005017103A3 (fr) Synthases d'oxyde nitrique d'origine bacterienne et leur utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004717665

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004717665

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006218665

Country of ref document: US

Ref document number: 10547563

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10547563

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2004717665

Country of ref document: EP